Literature DB >> 20082877

Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.

Ruqiong Nie1, Shuanglun Xie, Bin Du, Xiaoyan Liu, Bingqing Deng, Jingfeng Wang.   

Abstract

BACKGROUND AND AIMS: Elevated activities of matrix metalloproteinases (MMPs) following acute myocardial infarction (AMI) have been shown to mediate ventricular remodeling. The extracellular MMP inducer (EMMPRIN) plays a key regulatory role for MMP activities. The aim of this study was to evaluate changes of EMMPRIN, MMP-2 and MMP-9 and determine the correlation between EMMPRIN expression and MMPs in human left ventricle after AMI.
METHODS: Immunohistochemistry for MMP-2, MMP-9 and EMMPRIN were performed postmortem in 15 human left ventricles including 10 patients with AMI and five normal subjects who were accident victims. Western blot was used to determine protein levels of MMP-2, MMP-9 and EMMPRIN. The correlation between EMMPRIN expression and MMPs was determined by linear regression.
RESULTS: Our results showed that there was slight EMMPRIN expression on the membranes of normal cardiac myocytes, whereas its expression strongly increased around the zone of necrosis in the AMI group. Compared with the control group, EMMPRIN (1.10+/-0.17 vs. 0.25+/-0.04, p<0.001), MMP-2 (0.25+/-0.03 vs. 0.64+/-0.11, p<0.001) and MMP-9 (0.16+/-0.03 vs. 0.39+/-0.07, p<0.001) protein levels were significantly increased in the AMI group. The expression of MMP-2 (r(2)=0.82, p<0.001), and MMP-9 (r(2)=0.424, p=0.041) were correlated with EMMPRIN expression in AMI patients.
CONCLUSIONS: Our findings demonstrate for the first time that EMMPRIN expression increases in the human left ventricle after AMI. As one of the upregulators of local MMP expression, augmented expression of EMMPRIN may play a critical role in ventricular remodeling in AMI subjects. 2009 IMSS. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20082877     DOI: 10.1016/j.arcmed.2009.09.001

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  11 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

2.  Knockdown of EMMPRIN improves adverse remodeling mediated by IL-18 in the post-infarcted heart.

Authors:  Zizhuo Su; Rongjie Lin; Yuyang Chen; Xiaorong Shu; Haifeng Zhang; Ruqiong Nie; Jingfeng Wang; Shuanglun Xie
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 3.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

4.  Impact of artificial capnothorax on coagulation in patients during video-assisted thoracoscopic esophagectomy for squamous cell carcinoma.

Authors:  Qing-Xiang Mao; Wei Guo; Bing-Qiang Huang; Hong Yan
Journal:  Surg Endosc       Date:  2015-11-12       Impact factor: 4.584

5.  The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.

Authors:  Eline Bredal Furenes; Trine Baur Opstad; Svein Solheim; Ketil Lunde; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Mediators Inflamm       Date:  2014-09-11       Impact factor: 4.711

6.  Upregulation of EMMPRIN (OX47) in Rat Dorsal Root Ganglion Contributes to the Development of Mechanical Allodynia after Nerve Injury.

Authors:  Qun Wang; Yanyuan Sun; Yingna Ren; Yandong Gao; Li Tian; Yang Liu; Yanan Pu; Xingchun Gou; Yanke Chen; Yan Lu
Journal:  Neural Plast       Date:  2015-11-30       Impact factor: 3.599

7.  Basigin rs8259 Polymorphism Confers Decreased Risk of Chronic Heart Failure in a Chinese Population.

Authors:  Mu-Peng Li; Xiao-Lei Hu; Yong-Long Yang; Yan-Jiao Zhang; Ji-Peng Zhou; Li-Ming Peng; Jie Tang; Xiao-Ping Chen
Journal:  Int J Environ Res Public Health       Date:  2017-02-21       Impact factor: 3.390

8.  Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway.

Authors:  Xing Liang; Li-Xia Yang; Ruiwei Guo; Yankun Shi; Xianhua Hou; Zhihua Yang; Xiaobin Zhou; Hong Liu
Journal:  Exp Ther Med       Date:  2017-01-19       Impact factor: 2.447

9.  The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension.

Authors:  Chang-yi Li; Wang Deng; Xiu-qing Liao; Jia Deng; Yu-kun Zhang; Dao-xin Wang
Journal:  Eur J Med Res       Date:  2013-06-05       Impact factor: 2.175

10.  EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.

Authors:  Irene Cuadrado; Maria Jose Garcia Miguel Piedras; Irene Herruzo; Maria Del Carmen Turpin; Borja Castejón; Paula Reventun; Ana Martin; Marta Saura; Jose Luis Zamorano; Carlos Zaragoza
Journal:  Theranostics       Date:  2016-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.